Hereditary breast cancer (HBC) accounts for 5–10% of breast cancer cases and it significantly increases the lifetime risk of cancer. Our objective was to evaluate the sociodemographic variables, family history of cancer, breast cancer (BC) screening practices and the risk profile of cancer affected or asymptomatic at-risk women that undergo genetic counseling for hereditary breast cancer in public Brazilian cancer genetics services. Estimated lifetime risk of BC was calculated for asymptomatic women using the Gail and Claus models. The majority of women showed a moderate lifetime risk of developing BC, with an average risk of 19.7% and 19.9% by the Gail and Claus models, respectively. The average prior probability of carrying a BRCA1/2 gene mutation was 16.7% and overall only 32% fulfilled criteria for a hereditary breast cancer syndrome as assessed by family history. We conclude that a significant number of individuals at high-risk for HBC syndromes may not have access to the benefits of cancer genetic counseling in these centers. Contributing factors may include insufficient training of healthcare professionals, disinformation of cancer patients; difficult access to genetic testing and/or resistance in seeking such services. The identification and understanding of these barriers is essential to develop specific strategies to effectively achieve cancer risk reduction in this and other countries were clinical cancer genetics is not yet fully established.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Achatz, M. I. W., & Hainaut, P. (2005). TP53 gene and Li-Fraumeni syndrome. Appl Cancer Res, 25, 51–57.
ASCO Subcommittee on Genetic Testing for Cancer Susceptibility (1996). Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility. J Clin Oncol, 14, 1730–1736.
Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., et al. (1994). Prevalence and diversity of constitutional mutations in the p53 gene among Li-Fraumeni families. Cancer Res, 54, 1298–1304.
Borras, J. M., Guillen, M., Sanchez, V., Junca, S., & Vicente, R. (1999). Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev, 8, 427–434.
Claus, E. B., Risch, N., & Thompson, D. (1994). Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer, 73, 643–651.
Easton, D. F. (1999). How many more breast cancer predisposition genes are there? Br Cancer Res, 1(1), 14–17.
Eisen, A., Rebbeck, T. R., Wood, W. C., & Weber, B. L. (2000). Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol, 18, 1980–1995.
Eng C. (1997). Cowden syndrome. J Genet Counsel, 6, 181.
Epplein, M, Koon, K. P., Ramsey, S. D., & Potter, J. D. (2005). Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. J Clin Oncol, 23(21), 4713–4718.
Evans, D. G. R., Burnell, L. D., Hopwood, P., & Howell, A. (1993). Perception of risk in women with a family history of breast cancer. Br J Cancer, 67, 612–614.
Frank, T. S., Manley, S. A., Olopade, O. I., Cummings, S., Garber, J. E., Bernhardt, B., et al. (1998). Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol, 16, 2417–2425.
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., et al. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst, 81, 1879–1886.
Gorin, S. S., & Heck, J. E. (2005). Cancer screening among Latino subgroups in the United States. Prev Med, 40, 515–526.
Hopwood, P. (2000). Breast cancer risk perception: what do we know and understand? Br Cancer Res, 2, 387–391.
Huiart, L., Eisinger, F., Stoppa-Lyonnet, D., Lasset, C., Noguès, C., Vennin, P., et al. (2002). Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultation. J Clin Epidemiol, 55, 665–675.
Julian-Reynier, C., Eisinger, F., Chabal, F., Aurran, Y., Nogues, C., Vennin, P., et al. (1996). Cancer genetics clinics: target population and consultees’expectations. Eur J Cancer, 32A(3), 391–403.
Julian-Reynier, C., Eisinger, F., Chabal, F., Aurran, Y., Bignon, Y. J., Nogues, C., et al. (1998). Cancer genetics clinics: why do women who already have cancer attend? Eur J Cancer, 34(10), 1549–1553.
Lerman, C., Rimer, B. K., Daly, M., Lustbader, E., Sands, C., Blashem, A., et al. (1994). Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiol Biomarkers Prev, 3, 271–276.
Leventhal, H., Kelly, K., & Leventhal, E. A. (1999). Population risk, actual risk, perceived risk, and cancer control: a discussion. J Natl Cancer Inst Monographs, 25, 81–85.
Li, F. P., & Fraumeni, J. F. Jr. (1969). Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med, 71, 747–752.
Llerena, J. C. Jr. (2002). Medical Genetics, Single Brazilian Health System (SUS) and integrated aspect in health attention and care. Ciência & Saúde Coletiva, 7, 17–41.
Meijers-Heijboer, H., Wijnen, J., Vasen, H., Wasielewski, M., Wagner, A., Hollestelle, A., et al. (2003). The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet, 72, 1308–1314.
Miki, Y., Swenson, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66–71.
Offit, K. (1998). The common hereditary cancers. In: Clinical cancer genetics: Risk counseling and management (pp. 66–156). New York: Wiley-Liss.
Penchaszadeh, V. B. (2000). Community genetics in Latin America: challenges and perspectives. Community Genet, 3, 124–127.
Penchaszadeh, V. B., Christianson, A. L., Giugliani, R., Boulyjenkov, V., & Katz, M. (1999). Services for the prevention and management of genetic disorders and birth defects in developing countries. Community Genet, 2, 196–201.
Ritvo, P., Irvine, J., Robinson, G., Brown, L., Murphy, K. J., Matthew, A., et al. (2002). Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations. Gynecol Oncol, 84, 72–80.
Sobol, H., Bignon, Y. J., Bonaiti, C., Cuisinger, J., Lasset, C., Lortholary, A., et al. (1999). Four years analysis of cancer genetics clinics activities in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Genetique et Cancer de la Federation Nationale des Centres de Lutte Contre le Cancer. Dis Markers, 15(1–3), 15–29.
Thorson, A. G., Knezetic, J. A., & Lynch, H. T. (1999). A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome). Dis Colon Rectum, 42(1), 1–9.
U.S. Preventive Services Taskforce (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med, 143(5), 355–361.
Wonderling, D., Hopwood, P., Cull, A., Douglas, F., Watson, M., Burn, J., et al. (2001). A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. Br J Cancer, 85(2), 166–170.
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., et al. (1994). Localization of a breast cancer susceptibility gene, BRCA2 to chromosome 13q12-13. Science, 265, 2088–2090.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Palmero, E.I., Ashton-Prolla, P., da Rocha, J.C.C. et al. Clinical Characterization and Risk Profile of Individuals Seeking Genetic Counseling for Hereditary Breast Cancer in Brazil. J Genet Counsel 16, 363–371 (2007). https://doi.org/10.1007/s10897-006-9073-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-006-9073-0